Teladoc Health Q1 2026 Earnings Miss Estimates as Revenue Declines
Teladoc Health reported Q1 2026 results with a narrower year-over-year net loss, but revenue fell short of analyst expectations due to continued weakness in its BetterHelp mental health platform and declining subscriptions.
Key Numbers
Teladoc Health (NYSE: TDOC) reported its first-quarter 2026 financial results, posting a narrower net loss compared to the same period last year, but revenue missed analyst estimates as the company's BetterHelp mental health platform continued to underperform and subscription numbers declined.
Key Financial Results
| Metric | Q1 2026 | Q1 2025 | Change |
|---|---|---|---|
| Revenue | TBD | TBD | - |
| Net Loss | TBD | TBD | - |
| EPS | TBD | TBD | - |
Note: Exact figures were not provided in the original source. The table will be updated when data becomes available.
Highlights from the Release
- BetterHelp Weakness: Revenue from the BetterHelp mental health platform continued to decline, weighing on overall results.
- Subscription Decline: The number of subscribers to Teladoc's core services fell, impacting recurring revenue.
- International Growth: International operations posted growth, partially offsetting weakness in the U.S. market.
- Cost Cuts: Cost reduction measures helped narrow the net loss compared to last year.
Guidance
The company did not provide formal guidance for the next quarter or fiscal year 2026 in this release.
Stock Impact
Teladoc Health shares (TDOC) declined in after-hours trading following the announcement, as investors reacted to persistent BetterHelp weakness and slowing subscription growth.
What This Means for Investors
The Q1 results indicate that Teladoc continues to face structural challenges in the mental health segment, despite success in reducing costs. Investors should monitor subscription growth and BetterHelp performance in upcoming quarters to assess the company's ability to return to growth.
Frequently Asked Questions
Found this useful? Share it